Form 4: VolitionRx Officer's Future Stock Transaction for Tax Withholding Detailed in SEC Filing
Insider Transaction Report
A recent SEC Form 4 filing reveals that VolitionRx's GC, Nicholas Plummer, will have 5,417 shares of common stock withheld by the company in July 2025 to cover tax obligations related to the settlement of restricted stock units.
Summary
- Nicholas Plummer, General Counsel of Volition Diagnostics, an officer of VolitionRx Ltd. (VNRX), is the reporting person.
- The filing details a future transaction scheduled for July 1, 2025.
- VolitionRx will retain 5,417 shares of common stock from Nicholas Plummer to satisfy tax withholding obligations.
- This withholding is associated with the settlement of 11,527 restricted stock units (RSUs) that were awarded to Mr. Plummer in lieu of cash compensation.
- The price per share for the withheld stock is $0.7679.
- Following this transaction, Mr. Plummer's direct beneficial ownership will be 188,297 shares of common stock.
- No shares were sold by either Mr. Plummer or VolitionRx in this transaction; the shares were simply withheld for tax purposes.
Sentiment
Score: 5
Explanation: The transaction is a routine, non-discretionary tax withholding related to equity compensation, which is a neutral event for company valuation and operations.
Positives
- The award of 11,527 restricted stock units (RSUs) to the General Counsel in lieu of cash compensation indicates a non-cash compensation strategy, which can help preserve the company's cash reserves.
- The transaction is a routine tax withholding, not a discretionary sale by the insider, suggesting no intent to divest personal holdings beyond tax obligations.
Negatives
- The reporting person's direct beneficial ownership of common stock will decrease by 5,417 shares due to the tax withholding.
Future Outlook
The filing indicates a future transaction scheduled for July 1, 2025, where 5,417 shares of common stock will be withheld by VolitionRx to satisfy tax obligations related to the settlement of 11,527 restricted stock units awarded to Nicholas Plummer. This is a pre-scheduled, routine event.
Industry Context
Form 4 filings are standard regulatory disclosures for insider transactions, providing transparency into changes in beneficial ownership by company officers, directors, and significant shareholders. This specific filing details a common practice where shares are withheld to cover tax liabilities upon the vesting or settlement of equity awards, such as restricted stock units, rather than requiring the insider to pay cash out-of-pocket. This is a routine event in executive compensation.
Comparison to Industry Standards
- The practice of withholding shares to cover tax obligations upon the vesting of restricted stock units is a common and standard method of managing equity compensation in publicly traded companies across various industries.
- Companies like Apple Inc. (AAPL), Microsoft Corp. (MSFT), and Amazon.com Inc. (AMZN) frequently report similar Form 4 transactions for their executives, where a portion of vested equity awards is withheld by the company to satisfy statutory tax requirements.
- This mechanism is widely accepted as an efficient way to handle the tax implications of equity compensation, avoiding the need for executives to sell shares on the open market solely to cover tax liabilities, which could otherwise send negative signals.
Related Party Transactions
- This document reports an insider transaction (equity award settlement and tax withholding for an officer), which is a common form of transaction between a company and its executives. It does not disclose any unusual or non-standard related party dealings beyond routine compensation.
Stakeholder Impact
- Shareholders: Minimal direct impact as it's a routine tax withholding, not a discretionary sale by an insider. It reflects standard executive compensation practices.
- Employees: No direct impact on general employees.
- Customers: No direct impact.
- Suppliers: No direct impact.
- Creditors: No direct impact.
Next Steps
- The reported transaction of 5,417 shares being withheld for tax purposes is scheduled to occur on July 1, 2025.
Key Dates
| Date | Description |
|---|---|
| 07/01/2025 | Date of the reported transaction where shares will be withheld for tax obligations. |
| 07/03/2025 | Date the Form 4 was signed by Nicholas Plummer. |
Keywords
VolitionRx, VNRX, Nicholas Plummer, SEC Form 4, insider transaction, stock, common stock, restricted stock units, RSU, tax withholding, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.